Dave Nichols has more than 25 years of experience in process development and GMP clinical and commercial manufacturing for biologics, including antibody drug conjugates (ADC) and small molecules, as well as analytical development and quality control, cold chain logistics and management.

Prior to joining Lifordi, Mr. Nichols was Chief Technology Officer at Magenta and a member of the Executive Team. While at Magenta, he led CMC activities from early development through late-stage clinical development and production, including driving strategic initiatives to ensure comparability, compliance and risk mitigation for ADCs, cell therapy, and peptide manufacturing processes. Before Magenta, Mr. Nichols served as Senior Vice President of Technical Operations at Kiniksa Pharmaceuticals, Ltd., where he was responsible for process development and internal and external GMP manufacturing across the portfolio, supply chain, device and quality control initiatives. Previously, Mr. Nichols held positions of increasing responsibility at leading pharmaceutical companies including Head of CMC Biologicals Drug Substances at Tesaro; Senior Director of Process Development at Operations at Teva; and Senior Director, CMC Integration at Shire.

Mr. Nichols holds an M.B.A. from Northeastern University and a M.S. in Biochemistry from the University of New Hampshire.